Single-Cell RNA Sequencing Reveals Cellular Heterogeneity in an Acral Amelanotic Melanoma After Immunotherapy Treatment

BACKGROUND: Anti-programmed cell death ligand-1 (anti-PD-L1) immunotherapy is often used for advanced urothelial carcinoma and melanoma, including amelanotic melanoma, a relatively rare subtype with little to no pigment in the tumor cells. However, cellular heterogeneity of amelanotic melanoma durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Le, Tian, Jie, Lai, Binbin, Zhang, Guohong, Li, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108909/
https://www.ncbi.nlm.nih.gov/pubmed/37077860
http://dx.doi.org/10.2147/CCID.S404381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108909/
https://www.ncbi.nlm.nih.gov/pubmed/37077860
http://dx.doi.org/10.2147/CCID.S404381

Ejemplares similares